Martindale Pharma agrees new supply agreement with Burton Hospitals NHS Foundation Trust

Published: 31-May-2016
Pharmaceutical

Strategic and trusted supplier of essential medicines to the NHS


Martindale Pharma, a UK based international specialist pharmaceutical company, has signed a new multi-year exclusive manufacturing agreement with Burton Hospitals NHS Foundation Trust.

Under the terms of the agreement, Burton Hospitals NHS Foundation Trust will supply a number of Martindale Pharma’s speciality generic products including Bismuth Iodoform Paraffin Paste (BIPP) and Lidocaine and Phenylephrine Topical Solution, which are both routine treatments in Ear Nose and Throat (ENT) surgery.

Financial terms were not disclosed.

This news follows two years of collaborative work with the Burton Hospital

Michael Clark, Chief Marketing Officer, said: 'This news follows two years of collaborative work with the Burton Hospital, one of our best performing contract manufacturing partners. We believe this new agreement demonstrates how pharmaceutical companies can support NHS manufacturing units and offer patients the best drugs currently available on the market.'

Martindale Pharma has maintained a close partnership with NHS manufacturing units over the years, as well as supporting NHS staff with training. For the past six years, the firm has worked with the UCL School of Pharmacy and London North West Healthcare NHS Trust’s Q3P Qualified Person (QP) Training Course providing academic and practical training to NHS Qualified Person trainees; as part of the course the pharmaceutical packaging module is hosted annually at Martindale Pharma’s Romford facility in Essex.

Clark added 'We are very pleased to be able to share our expertise and knowledge in the manufacturing industry with trainee QPs and NHS Manufacturing units. Our expertise, combined with our modern, upgraded UK manufacturing facility not only allows us to manufacture high quality medicines efficiently, but also supply these to a wide range of countries and healthcare systems, notably the UK where we have over 100 different products on contract to supply the NHS.'

  • Companies:
  • Martindale Pharma
See more

You may also like

Drug Delivery

French Ethypharm acquires Martindale Pharma

Read more
Independent pharmaceutical company Ethypharm reinforces its UK presence by acquiring Martindale Pharma

Trending Articles

  1. Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
  2. How pharma packaging manufacturers role is evolving: the case of extractables testing As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
  3. Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
  4. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  5. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Drug Delivery

French Ethypharm acquires Martindale Pharma

Independent pharmaceutical company Ethypharm reinforces its UK presence by acquiring Martindale Pharma
Drug Delivery

Martindale Pharma launches first licensed oral liquid solution of captopril

Noyada is available in two presentations to maximise accuracy and flexibility of dosing
Drug Delivery

Martindale Pharma launches first emergency treatment for acute opioid overdose

Contains a solution of naloxone hydrochloride
Packaging

Innovating primary packaging for parenteral drugs: challenges and future directions

The new challenges brought about by the pandemic call for an increasingly scientific approach to the evolution of single packaging elements in order to anticipate the needs of new drug formulations and guarantee a more enhanced, measurable and stable level of performance
Regulatory

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Regulatory

Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China

The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
Subscribe now